Delivery Order SPE2DB20D2104-SPE2DB24FU83N
Award Date
6/24/24
Potential Completion Date
6/25/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,532.58 firm fixed-price delivery order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $14,634.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a completion date of December 12, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,290.79 firm fixed-price delivery order is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to support military healthcare programs. The contract has an ultimate completion date of December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,682.02 delivery order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a period of performance through January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $5,164.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a critical medical product used for infectious disease prevention. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,394.26, is a firm fixed-price delivery order for the supply of 4566199282 BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to support military and federal healthcare programs. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,564,353 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a ceiling value of $36,781.92 and an ultimate completion date of April 23, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
The U.S. Defense Logistics Agency (DLA) awarded a $33,555.84 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract...
This federal contract award, valued at $1,268.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560497883 Boostrix TDAP vaccine syringes, 0.5ML. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,109.44 firm fixed-price delivery order is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a completion date of September 12, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...